The impact of anxiety and depression on hematologic malignancy outcomes: a systematic review and meta-analysis
Dorsa Salabat, Samaneh Toutounchian, Danyal Salabat, Armin Babaei, Mahda Malekshahi, Maryam Barkhordar, Zahra Salehi · 2025
Read The impact of anxiety and depression on hematologic malignancy outcomes: a systematic review and meta-analysis by Dorsa Salabat, Samaneh Toutounchian, Danyal Salabat, Armin Babaei, Mahda Malekshahi, Maryam Barkhordar, Zahra Salehi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12723824.txt.
Description
Seven authors pool evidence on mood and survival in blood cancers in this 2025 review. Depression and anxiety are common in patients with leukemia, lymphoma, and related diseases, but whether they shorten life was unsettled.
Following standard review methods, the team searched three databases and gathered twenty-nine studies covering over four hundred thousand patients. Depression came with clearly worse overall survival, with risk about seventeen percent higher. Anxiety's link was weaker and not statistically firm for overall survival. Event free and cause specific survival showed a mixed pattern, which the authors probed with subgroup and bias checks. The message is that treating depression may matter for outcomes, not only comfort.
Catalog record
| CREATOR | Dorsa Salabat, Samaneh Toutounchian, Danyal Salabat, Armin Babaei, Mahda Malekshahi, Maryam Barkhordar, Zahra Salehi |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |